Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection

Documenti analoghi

• The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
  di: Yishan Lu, et al.
  Pubblicazione: (2024)
• Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
  di: Shuo Liu, et al.
  Pubblicazione: (2024)
• Targeting esophageal carcinoma: molecular mechanisms and clinical studies
  di: Wenjing Wang, et al.
  Pubblicazione: (2024)
• Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad‐Neutralizing Antibody Response against SARS‐CoV‐2 Omicron Subvariants
  di: Guangxu Zhang, et al.
  Pubblicazione: (2025)
• Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system
  di: Ziteng Liang, et al.
  Pubblicazione: (2024)